Itron (NASDAQ:ITRI) CFO Sells $28,258.00 in Stock

Itron, Inc. (NASDAQ:ITRI) CFO Joan Hooper sold 355 shares of Itron stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total value of $28,258.00. Following the sale, the chief financial officer directly owned 117,920 shares of the company’s stock, valued at approximately $9,386,432. This trade represents a 0.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Trading Up 1.4%

Shares of NASDAQ ITRI opened at $83.02 on Friday. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. The business has a fifty day simple moving average of $88.45 and a two-hundred day simple moving average of $94.52. The firm has a market cap of $3.68 billion, a PE ratio of 13.24, a price-to-earnings-growth ratio of 0.73 and a beta of 1.35. Itron, Inc. has a twelve month low of $77.77 and a twelve month high of $142.00.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The business had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.Itron’s revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Analysts expect that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. DLD Asset Management LP grew its stake in Itron by 49.9% during the 3rd quarter. DLD Asset Management LP now owns 63,400 shares of the scientific and technical instruments company’s stock worth $7,897,000 after buying an additional 21,100 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in Itron by 78.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 77,488 shares of the scientific and technical instruments company’s stock worth $9,653,000 after buying an additional 34,027 shares during the last quarter. Elo Mutual Pension Insurance Co purchased a new position in Itron during the 3rd quarter worth $1,672,000. J. Safra Sarasin Holding AG purchased a new position in Itron during the 3rd quarter worth $4,673,000. Finally, Envestnet Asset Management Inc. grew its stake in Itron by 34.0% during the 3rd quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company’s stock worth $18,474,000 after buying an additional 37,634 shares during the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
• Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
• Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

Wall Street Analysts Forecast Growth

ITRI has been the subject of several recent research reports. Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Raymond James Financial initiated coverage on Itron in a research report on Tuesday, April 21st. They issued an “underperform” rating for the company. TD Cowen reduced their price target on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Oppenheimer boosted their price target on Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday, April 16th. Finally, Guggenheim set a $155.00 price target on Itron in a research report on Friday, February 13th. Eight equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.